Status:
UNKNOWN
Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails
Lead Sponsor:
Rosalind Franklin University of Medicine and Science
Conditions:
Ingrown Nail
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study's purpose is to prospectively determine whether topical therapy with an oxidized regenerated cellulose collagen-silver compound is more effective than the current standard of topical antibi...
Eligibility Criteria
Inclusion
- Ingrown toenails will be defined as any incurvated nail border that digs into the skin of the nail fold and causes pain and discomfort
Exclusion
- Patients with immunocompromised states
- chronic steroid use
- diabetes mellitus
- collagen vascular disease
- HIV infection
- Cellulitis proximal to the hallux interphalangeal joint or peripheral vascular disease will be excluded
- We will define peripheral vascular disease as the absence of one or more pedal pulses or the presence of dystrophic changes to the integument
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00641433
Start Date
November 1 2005
End Date
May 1 2008
Last Update
March 24 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Scholl Foot and Ankle Center
North Chicago, Illinois, United States, 60064
2
Preofessional Education and Research Institutue
Roanoke, Virginia, United States, 24016